Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Uterine Cervical Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Nasopharyngeal Carcinoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 31Fluorouracil 24Paclitaxel 19Radiotherapy 15Docetaxel 11Esophagectomy 8Radiation 7Neoadjuvant Therapy 7Irinotecan 6Carboplatin 6Oxaliplatin 5Leucovorin 5Capecitabine 5sintilimab 4pembrolizumab 4camrelizumab 4TP protocol 4Surgical Procedures, Operative 4Drug Therapy 4Chemotherapy, Adjuvant 4Trastuzumab 3Immunotherapy 3Epirubicin 3Chemoradiotherapy 3tislelizumab 2nimotuzumab 2S 1 (combination) 2Radiotherapy, Adjuvant 2Platinum Compounds 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Esophageal Neoplasms × Control Groups × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡